133 related articles for article (PubMed ID: 8299122)
1. Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas.
Végh Z; Wang P; Vánky F; Hising C; Sjöwall K; Larsson B; Klein E
Cancer Immunol Immunother; 1994 Jan; 38(1):71-3. PubMed ID: 8299122
[TBL] [Abstract][Full Text] [Related]
2. Expression of MHC-class-I antigens in human carcinomas and sarcomas analyzed by isoelectric focusing.
Wang P; Vánky F; Li SL; Végh Z; Persson U; Klein E
Int J Cancer Suppl; 1991; 6():106-16. PubMed ID: 2066176
[TBL] [Abstract][Full Text] [Related]
3. Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas.
Wang P; Vánky F; Klein E
Cancer Immunol Immunother; 1991; 33(1):65-9. PubMed ID: 2021960
[TBL] [Abstract][Full Text] [Related]
4. Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors.
Végh Z; Wang P; Vánky F; Klein E
Cancer Res; 1993 May; 53(10 Suppl):2416-20. PubMed ID: 8485728
[TBL] [Abstract][Full Text] [Related]
5. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes.
Vánky F; Hising C; Sjöwall K; Larsson B; Rodriguez L; Orre L; Klein E
Cancer Immunol Immunother; 1995 Oct; 41(4):217-26. PubMed ID: 7489564
[TBL] [Abstract][Full Text] [Related]
7. Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
Leffers N; Lambeck AJ; de Graeff P; Bijlsma AY; Daemen T; van der Zee AG; Nijman HW
Gynecol Oncol; 2008 Sep; 110(3):365-73. PubMed ID: 18571704
[TBL] [Abstract][Full Text] [Related]
8. NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.
Le Maux Chansac B; Moretta A; Vergnon I; Opolon P; Lécluse Y; Grunenwald D; Kubin M; Soria JC; Chouaib S; Mami-Chouaib F
J Immunol; 2005 Nov; 175(9):5790-8. PubMed ID: 16237071
[TBL] [Abstract][Full Text] [Related]
9. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
10. Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.
Vánky F; Stuber G; Willems J; Sjöwall K; Larsson B; Böök K; Ivert T; Péterffy A; Klein E
Cancer Immunol Immunother; 1988; 27(3):213-22. PubMed ID: 2972365
[TBL] [Abstract][Full Text] [Related]
11. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
[TBL] [Abstract][Full Text] [Related]
12. The role of surface HLA-A,B,C molecules in tumour immunity.
Möller P; Hämmerling GJ
Cancer Surv; 1992; 13():101-27. PubMed ID: 1423320
[TBL] [Abstract][Full Text] [Related]
13. Induction of MHC class I expression by the MHC class II transactivator CIITA.
Martin BK; Chin KC; Olsen JC; Skinner CA; Dey A; Ozato K; Ting JP
Immunity; 1997 May; 6(5):591-600. PubMed ID: 9175837
[TBL] [Abstract][Full Text] [Related]
14. MHC class I expression on human tumour cells and their susceptibility to NK lysis.
Pena J; Solana R; Alonso MC; Santamaria M; Serrano R; Ramirez R; Carracedo J
J Immunogenet; 1989; 16(4-5):407-12. PubMed ID: 2517951
[TBL] [Abstract][Full Text] [Related]
15. Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-gamma or by a binding peptide.
Wang P; Vánky F; Végh Z; Persson U; Hising C; Klein E
Cell Immunol; 1992 Jul; 142(2):296-302. PubMed ID: 1623553
[TBL] [Abstract][Full Text] [Related]
16. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
17. Competition between MHC class I alleles for cell surface expression alters CTL responses to influenza A virus.
Tourdot S; Gould KG
J Immunol; 2002 Nov; 169(10):5615-21. PubMed ID: 12421940
[TBL] [Abstract][Full Text] [Related]
18. Evidence for cytotoxic T lymphocyte response against human lung cancer: reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I.
Calhoun RF; Naziruddin B; Enriquez-Rincon F; Duffy BF; Ritter JM; Sundaresan S; Patterson GA; Cooper JD; Mohanakumar T
Surgery; 2000 Jul; 128(1):76-85. PubMed ID: 10876189
[TBL] [Abstract][Full Text] [Related]
19. Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cells.
Takenoyama M; Yoshino I; Fujie H; Hanagiri T; Yoshimatsu T; Imabayashi S; Eifuku R; Nomoto K; Yasumoto K
Jpn J Cancer Res; 1998 Jan; 89(1):60-6. PubMed ID: 9510477
[TBL] [Abstract][Full Text] [Related]
20. A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.
Okada Y; Yahata G; Takeuchi S; Seidoh T; Tanaka K
Jpn J Cancer Res; 1989 Mar; 80(3):249-56. PubMed ID: 2524461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
